ArticleBreast cancer research and treatment2022

PTEN promoter methylation predicts 10-year prognosis in hormone receptor-positive early breast cancer patients who received adjuvant tamoxifen endocrine therapy.

Yu Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.